S Arlot

Efficacy of the Long-Acting Octreotide Formulation (Octreotide-Lar) in Patients with Thyrotropin-Secreting Pituitary Adenomas

Philippe Caron, S Arlot, Catherine Bauters et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 120 citations

Monthly Im Injections, Pituitary Gland, Medicine +14

Increased Prevalence of Hypothyroidism among Human Immunodeficiency Virus—Infected Patients: A Need for Screening

Sonia Beltran, François-Xavier Lescure, Rachel Desailloud et al. · Clinical Infectious Diseases · 2003 · 102 citations · Full text

Evaluation of the Treatment of Thyrotropin-Secreting Pituitary Adenomas with a Slow Release Formulation of the Somatostatin Analog Lanreotide

Jean‐Marc Kuhn, S Arlot, Hervé Lefèbvre et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 96 citations · Full text

Myxoedema coma: Response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment

S Arlot, Xavier Debussche, Jean‐Daniel Lalau et al. · Intensive Care Medicine · 1991 · 74 citations

Thyroid Disease, Myxoedema Coma, Thyroid Disorders +4

Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study

Jean‐François Cadranel, Vincent Di Martino, G Lambrey et al. · European Journal of Gastroenterology & Hepatology · 2008 · 30 citations